Overview

A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

Determine whether dalfampridine (Ampyra) can improve visual function in patients who have had nonarteritic ischemic optic neuropathy (NAION) with stable visual impairment.

Phase:

Phase 4

Details

Lead Sponsor:

Neuro-Ophthalmologic Associates, PC

Collaborator:

Acorda Therapeutics

Treatments:

4-Aminopyridine